The Mycoplasma Testing Market size is expected to grow at an annual average of 9% during 2021-2027. Mycoplasma contamination testing is an essential practice in the cell culture process. Mycoplasma is a small, simple bacterium, one of the most prevalent and serious sources of cell line contamination. Because these organisms do not have cell walls, they rapidly infect the entire cell culture, causing massive losses. So, to get better results, several companies are offering mycoplasma contamination testing solutions.
(Get 15% Discount on Buying this Report)
A full report of Mycoplasma Testing Market is available at: https://www.orionmarketreports.com/mycoplasma-testing-market/53838/
The following segmentation are covered in this report:
By Product
- Kits & Reagents
- Instruments
- Services
By Technique
- DNA Stain
- Enzyme-based
- PCR
- ELISA
- Direct Assay
- Indirect Assay
- Others
By Application
- Cell Line and Cell Therapy Testing
- Virus Testing
- Row Material Testing
- Lot Release Testing
- Others
Company Profile
- Agilent Technologies
- ATCC
- Bionique Testing Laboratories Inc.
- Charles River Laboratories International Inc.
- Eurofins Scientific
- Lonza Group Ltd
- Merck KGaA
- Bionique Testing Laboratories Inc.
- PromoCell GmbH
- Thermo Fisher Scientific Inc.
The report covers the following objectives:
- Proliferation and maturation of trade in the global Mycoplasma Testing Market
- The market share of the global Mycoplasma Testing Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Mycoplasma Testing Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Mycoplasma Testing Market
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
